Nathalie Dubois-Stringfellow
SVP-CHIEF DEVELOPMENT OFFICER · SANGAMO THERAPEUTICS, INC
IndividualSelling only
- 2024
- May 27, 2026
- 12
Filings (90d)
0
Purchases
0
Sales
1
Summary
Latest filing:
Nathalie Dubois-Stringfellow is SVP-CHIEF DEVELOPMENT OFFICER of SANGAMO THERAPEUTICS, INC (SGMO). 12 SEC Form 4 filings on record going back to 2024, most recently on 27 May 2026. Most recent open-market trade: sold $89K of SGMO on 23 April 2026. Lifetime open-market sales: $89K.
Recent transactions
13The latest 13 SEC Form 4 transactions reported by Nathalie Dubois-Stringfellow.
All13Sells1Withholding12
Trading pattern
InsiderAlpha's records for Nathalie Dubois-Stringfellow go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.